Acorah Software Products - Accounts Production 16.2.850 false true 5 April 2024 1 December 2022 false true No description of principal activity 6 April 2024 5 April 2025 5 April 2025 14519158 Dr Kee Wong iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14519158 2024-04-05 14519158 2025-04-05 14519158 2024-04-06 2025-04-05 14519158 frs-core:CurrentFinancialInstruments 2025-04-05 14519158 frs-bus:PrivateLimitedCompanyLtd 2024-04-06 2025-04-05 14519158 frs-bus:FilletedAccounts 2024-04-06 2025-04-05 14519158 frs-bus:Micro-entities 2024-04-06 2025-04-05 14519158 frs-bus:AuditExempt-NoAccountantsReport 2024-04-06 2025-04-05 14519158 frs-bus:Director1 2024-04-06 2025-04-05 14519158 2022-11-30 14519158 2024-04-05 14519158 2022-12-01 2024-04-05 14519158 frs-core:CurrentFinancialInstruments 2024-04-05
Registered number: 14519158
WKH Oncology Limited
Unaudited Financial Statements
For The Year Ended 5 April 2025
Sharpe Medical Accounting Ltd
Balance Sheet
Registered number: 14519158
5 April 2025 5 April 2024
£ £
Fixed assets 2,474 2,268
Current assets 72,912 49,611
Prepayments and accrued income 935 935
Creditors: Amounts Falling Due Within One Year (10,496 ) (12,081 )
NET CURRENT ASSETS 63,351 38,465
TOTAL ASSETS LESS CURRENT LIABILITIES 65,825 40,733
Accruals and deferred income (763 ) (720 )
NET ASSETS 65,062 40,013
CAPITAL AND RESERVES 65,062 40,013

Notes

1. General Information
WKH Oncology Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14519158 . The registered office is C/O Sharpe Medical Accounting Limited, Normanby Gateway, Lysaghts Way, Scunthorpe, North Lincolnshire, DN15 9YG.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
Page 0
Page 1
For the year ending 5 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Kee Wong
Director
20/06/2025